Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 50,080 | 42,646 | 40,086 | 38,742 | 27,196 |
| Cost of Goods | 30,682 | 26,103 | 24,235 | 22,590 | 18,079 |
| Gross Profit | 19,398 | 16,543 | 15,851 | 16,152 | 9,117 |
| Operating Expenses | 22,167 | 17,912 | 18,779 | 21,747 | 17,902 |
| Operating Income | -2,087 | -1,266 | -2,693 | -5,005 | -8,706 |
| Interest Expense | 1,706 | 2,073 | 2,037 | 2,091 | 1,630 |
| Other Income | 89 | 94 | 109 | 103 | 85 |
| Pre-tax Income | -3,704 | -3,245 | -4,621 | -6,993 | -10,251 |
| Income Tax | 20 | -17 | 63 | 15 | 36 |
| Net Income Continuous | -3,724 | -3,228 | -4,684 | -7,008 | -10,287 |
| Net Income | $-3,724 | $-3,228 | $-4,684 | $-7,008 | $-10,287 |
| EPS Basic Total Ops | -0.04 | -0.05 | -0.07 | -0.12 | -0.18 |
| EPS Basic Continuous Ops | -0.04 | -0.05 | -0.07 | -0.12 | -0.17 |
| EPS Diluted Total Ops | -0.04 | -0.05 | -0.07 | -0.12 | -0.18 |
| EPS Diluted Continuous Ops | -0.04 | -0.05 | -0.07 | -0.12 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.05 | -0.07 | -0.04 | -0.17 |
| EBITDA(a) | $217 | $1,352 | $-442 | $-2,598 | $-6,356 |